We're not taking orders right now. Feel free to explore Prescrivia, but no orders will be processed or fulfilled during this period.
Skip to content
Women's Health

How does the combined pill prevent pregnancy? Uses and missed-pill rules

By Prescrivia Editorial·Published Updated ·3 min read
Combined oral contraceptive pill packets
Dr. Fatimah Khan

Editorially reviewed by Dr Fatimah Khan, registered with the Pakistan Medical and Dental Council (PMDC no. 104595-P). Editorial medical reviewer; does not prescribe or review patient assessments.

Review details

Review recorded:

Review scope: This article edition.

Editorial reviewer for Prescrivia. Editorial review does not establish participation in patient consultations.

Clinical review does not replace individual medical advice. Prescrivia is a technology intermediary; independent doctors make clinical decisions.

Legal review: Qualified review pending.

Language review: Qualified review pending.

Source and review

Source published:

Attributed source update:

Text edited:

Editorial role: Editorial team. This description does not establish an individual credential or clinical review of this edition.

Read our editorial policy and corrections. Edit dates and source descriptions do not establish qualified review.

How does the combined pill prevent pregnancy?

The combined contraceptive pill contains oestrogen and progestogen. It prevents ovulation and is taken according to the instructions for the particular product. It does not protect against sexually transmitted infections.

The NHS combined-pill guide describes effectiveness as over 99% with consistently correct use and approximately 91% when not used correctly, measured over a year. These population estimates are not a guarantee for an individual.

Not every pack follows a 21/7 pattern

Pack or regimen What to check
21-day pill Instructions for active tablets and the planned break
Everyday pack Which tablets are active and which are inactive; the number varies
Tailored regimen The clinician's instructions for fewer or no breaks
Product with specific rules Its own starting and missed-pill leaflet, rather than a generic algorithm

NHS guidance identifies separate starting instructions for products such as Zoely and Qlaira. Do not assume that every everyday pack contains 21 active and seven inactive tablets.

If a pill is missed

Advice depends on the product, whether the tablet was active, how many were missed, where you are in the pack and whether unprotected sex occurred.

The Devon NHS sexual-health guide shows why timing matters:

  • Missing active pills around the beginning of a pack or extending a break can require assessment for emergency contraception.
  • Missing pills near the end of the active-tablet sequence can change whether a scheduled break should be taken.
  • Other situations have different requirements for additional protection.

Check your leaflet and contact a pharmacist or sexual-health clinician promptly with the pack name and dates. If unprotected sex occurred, do not delay advice while trying to interpret a generic rule: emergency contraception is time-sensitive. Vomiting, severe diarrhoea and interacting medicines can also affect protection.

This guide intentionally does not provide one missed-pill instruction for all formulations.

Suitability and monitoring

The NHS eligibility guidance identifies important factors including smoking at age 35 or over, clot or stroke history, migraine with aura, blood-pressure problems and certain cancers or liver conditions.

A clinician should apply the relevant eligibility criteria. A contraindication must not be softened by a blanket statement that “many are not absolute”. Review medicines, blood pressure and changing health circumstances, and discuss alternatives if oestrogen is unsuitable.

Preparing for assessment

Bring the exact pack, recent missed-tablet dates, other medicines and relevant health history. For a different menstrual question, see norethisterone and period delay; period-delay treatment is not interchangeable with contraception.

Prescrivia is an intermediary. Independent clinicians assess suitability; no prescription, access or contraceptive outcome is guaranteed.

General information only, not medical advice. Follow the leaflet for your actual product and discuss decisions with a qualified clinician. See the current clinical, legal and language review statuses for this edition.

Sources

Sources checked online on 6 October 2026. Country-specific guidance does not establish availability or prescribing rules throughout Europe.

Written by Prescrivia Editorial.

This content is informational only and does not constitute medical advice.

Last updated:

Related articles

Ready to start your assessment?

Read treatment information. An independent doctor decides whether assessment or treatment is appropriate; access depends on your country.